Language:

Guillain–Barré Syndrome due to COVID-19 Vero Cell Vaccination Associated with Concomitant COVID-19 Infection-induced ARDS and Treated Successfully by Therapeutic Plasma Exchange: A First Case Report from Vietnam

Pulmonary therapy, 2023-06, Vol.9 (2), p.271-280 [Peer Reviewed Journal]

The Author(s) 2023 ;2023. The Author(s). ;ISSN: 2364-1754 ;EISSN: 2364-1746 ;DOI: 10.1007/s41030-023-00219-x ;PMID: 36991236

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Guillain–Barré Syndrome due to COVID-19 Vero Cell Vaccination Associated with Concomitant COVID-19 Infection-induced ARDS and Treated Successfully by Therapeutic Plasma Exchange: A First Case Report from Vietnam
Author: Duong-Quy, Sy ; Huynh-Truong-Anh, Duc ; Nguyen-Quang, Tien ; Nguyen-Thi-Kim, Thanh ; Tran-Ngoc-Anh, Thuy ; Nguyen-Van-Hoai, Nam ; Do-Thi-Thu, Mai ; Nguyen-Van, Tinh ; Tang-Thi-Thao, Tram ; Nguyen-Tuan, Anh ; Nguyen-Van, Toi ; Tran-Xuan, Quynh ; Vu-Tran-Thien, Quan ; Trinh-Du, The ; Tran-Thai, Tuan ; Nguyen-Duy, Thai ; Tran-Van, Huong ; Vo-Thi-Kim, Anh
Subjects: ARDS ; Case Report ; COVID-19 ; Family Medicine ; General Practice ; Guillain–Barré syndrome ; Internal Medicine ; Medicine ; Medicine & Public Health ; Pharmacoeconomics and Health Outcomes ; Pharmacotherapy ; Pneumology/Respiratory System ; Quality of Life Research ; SARS-CoV-2 ; Vaccination ; Vero cell
Is Part Of: Pulmonary therapy, 2023-06, Vol.9 (2), p.271-280
Description: Post-vaccination adverse reactions have been reported with varying symptoms and severity owing to research and production time pressures during the coronavirus disease 2019 (COVID-19) pandemic. In this article, we report a rare case of Guillain–Barré syndrome (GBS) in a patient with COVID-19 with acute respiratory distress syndrome (ARDS) after receiving Sinopharm's Vero Cell vaccine (China). The patient who was initially negative for COVID-19 was diagnosed with GBS based on paralysis that developed from the lower extremities to the upper extremities, as confirmed by cytoalbuminologic dissociation in the cerebrospinal fluid. The patient's condition worsened with ARDS caused by COVID-19 infection during the hospital stay, and SpO 2 decreased to 83% while receiving oxygen through a non-rebreather mask (15 l/min) on day 6. The patient was treated with standard therapy for severe COVID-19, invasive mechanical ventilation, and five cycles of therapeutic plasma exchange (TPE) with 5% albumin replacement on day 11 due to severe progression. The patient was weaned off the ventilator on day 28, discharged on day 42, and was completely healthy after 6 months without any neurological sequelae until now. Our report showed the potential of TPE for GBS treatment in critically ill patients with COVID-19 after COVID-19 vaccination.
Publisher: Cheshire: Springer Healthcare
Language: English
Identifier: ISSN: 2364-1754
EISSN: 2364-1746
DOI: 10.1007/s41030-023-00219-x
PMID: 36991236
Source: PubMed Central
Springer Nature OA/Free Journals
ROAD: Directory of Open Access Scholarly Resources
DOAJ Directory of Open Access Journals

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Guillain–Barré Syndrome due to COVID-19 Vero Cell Vaccination Associated with Concomitant COVID-19 Infection-induced ARDS and Treated Successfully by Therapeutic Plasma Exchange: A First Case Report from Vietnam

The Author(s) 2023 ;2023. The Author(s). ;ISSN: 2364-1754 ;EISSN: 2364-1746 ;DOI: 10.1007/s41030-023-00219-x ;PMID: 36991236

Searching Remote Databases, Please Wait